VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (3)
A 24-week open-label extension study of memantine in moderate to severe Alzheimer disease.
Genome-wide scan for copy number variation association with age at onset of Alzheimer's disease.
Ultra-Wide-Field Fluorescein Angiography-Guided Normalization of Ischemic Index Calculation in Eyes With Retinal Vein Occlusion.
See All 3 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
A 24-week open-label extension study of memantine in moderate to severe Alzheimer disease.
A 24-week open-label extension study of memantine in moderate to severe Alzheimer disease. Arch Neurol. 2006 Jan; 63(1):49-54.
View in:
PubMed
subject areas
Aged
Aged, 80 and over
Alzheimer Disease
Disease Progression
Double-Blind Method
Excitatory Amino Acid Antagonists
Female
Humans
Male
Memantine
Mental Status Schedule
Neuropsychological Tests
Time Factors
Treatment Outcome
authors with profiles
RACHELLE DOODY